Infant botulism acquired from household dust presenting as sudden infant death syndrome by Nevas, M. et al.
JOURNAL OF CLINICAL MICROBIOLOGY, Jan. 2005, p. 511–513 Vol. 43, No. 1
0095-1137/05/$08.000 doi:10.1128/JCM.43.1.511–513.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Infant Botulism Acquired from Household Dust Presenting as
Sudden Infant Death Syndrome
Mari Nevas,1* Miia Lindstro¨m,1 Antti Virtanen,2 Sebastian Hielm,1 Markku Kuusi,3
Stephen S. Arnon,4 Erkki Vuori,2 and Hannu Korkeala1
Department of Food and Environmental Hygiene1 and Department of Forensic Medicine,2 University of Helsinki, Helsinki
University, and National Public Health Institute, Helsinki,3 Finland, and California Department
of Health Services, Richmond, California4
Received 15 July 2004/Returned for modification 25 July 2004/Accepted 5 September 2004
Clostridium botulinum type B was detected by multiplex PCR in the intestinal contents of a suddenly deceased
11-week-old infant and in vacuum cleaner dust from the patient’s household. C. botulinum was also isolated
from the deceased infant’s intestinal contents and from the household dust. The genetic similarity of the two
isolates was demonstrated by pulsed-field gel electrophoresis and randomly amplified polymorphic DNA
analysis, thereby confirming that dust may act as a vehicle for infant botulism that results in sudden death.
Clostridium botulinum is an anaerobic spore-forming bacte-
rium that produces botulinum neurotoxin, the causative agent
of botulism. The spores of C. botulinum, considered harmless
when ingested by healthy adults, may cause a toxigenic disease
when ingested by infants less than 1 year of age, in whom the
ingested spores may germinate, multiply, and produce toxin in
the intestinal lumen (12, 15). The severity of the resultant
illness may vary from an outpatient illness simulating failure to
thrive to death without preceding signs, thus resembling sud-
den infant death syndrome (SIDS) (1, 2). Honey is the only
spore-containing food item causally associated with infant bot-
ulism, but for the majority of cases the source of the causative
spores remains unclear (11). Identical toxin types of C. botu-
linum isolated from the patient’s surroundings, as well as from
the patient, have been identified (1). However, C. botulinum
organisms have also been detected in the environment of con-
trol infants who remained healthy (1). There are no previous
reports on the genotyping of such isolates that could aid in
ascertaining their epidemiologic association with the clinical
illness.
An 11-week-old boy died unexpectedly in January 2002 a few
hours after being fed, the final feeding being slower than nor-
mal. The baby was healthy and developing normally until his
sudden and unexpected death. The death of the infant was
classified by the pathologist as SIDS on the basis of the autopsy
findings.
The autopsy specimens of the child were investigated as a
part of a survey on the association of C. botulinum with SIDS
in Finland. Serum, feces, and autopsy sections from the intes-
tine and spleen were examined, as was the opened package of
the infant’s last meal of corn gruel.
The tissue samples and the corn gruel were inoculated in
several parallel 10-ml Trypticase-peptone-glucose-yeast extract
(TPGY) broths (8) and incubated under anaerobic conditions
at 37 or 30°C. Cells from the enrichment culture were har-
vested and washed with Tris-EDTA buffer in accordance with
a previously described method (6) in order to prepare a tem-
plate for PCR. The samples were studied with a multiplex PCR
assay targeted to the neurotoxin genes of C. botulinum types A,
B, E, and F (9). Toxin detection was performed on serum with
a mouse bioassay (13). Animal testing was performed in ac-
cordance with the national guidelines and with the permission
of the committee for animal experiments, University of Hel-
sinki. The amount of feces and intestinal contents was inade-
quate for the detection of toxin.
The C. botulinum type B toxin gene was identified by PCR in
two parallel samples of the infant’s intestinal contents, both
incubated at 37°C. C. botulinum was isolated from the PCR-
positive samples by plating 0.1 ml of TPGY broth on egg yolk
agar plates and incubating them under anaerobic conditions at
37°C for 2 days (19). C. botulinum type B was successfully
isolated from one of the intestinal specimens. All other au-
topsy specimens were negative for C. botulinum, and the serum
did not contain detectable botulinum toxin.
Family members of the deceased child were asked about the
previous health of the infant, his feeding and nursing habits,
the nearby environment, possible pets, and travel. Samples
collected from the household included soil from flower pots
and a vacuum cleaner dust bag. The child had been healthy
since birth except for a 2-day period of constipation at the age
of 4 weeks, but no signs of constipation preceded his death. He
had been breast fed until 6 weeks of age, after which the breast
milk had been gradually replaced with commercial formula
milk and corn gruel. Honey was not included at any point in
the infant’s diet. No environmental factors predisposing to
infant botulism, e.g., nearby construction (10), were noted.
The household samples were studied by multiplex PCR in a
total of 240 parallel assays to estimate the quantity of possible
C. botulinum spores in the patient’s environment by the most-
probable-number technique. The sample sizes were 40 g of soil
from the flower pots and 100 g of vacuum cleaner dust. Each
soil or dust subsample inoculated in TPGY broth weighed 1.0
or 0.5 g, respectively. The results obtained with these one-
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dilution most-probable-number series were used to calculate
an estimated spore count with Thomas’s approximation (18).
C. botulinum type B was detected by PCR in, and also iso-
lated from, the vacuum cleaner dust. The quantity of spores in
the dust was estimated to be 10/kg of examined material. The
other household samples were negative for C. botulinum by
TPGY culture and PCR analysis.
The C. botulinum isolates from the patient’s intestinal con-
tents and from the vacuum cleaner dust were confirmed to
produce botulinum toxin with a mouse bioassay. The proteo-
lytic activity of the isolates was demonstrated by plating the
strains on reinforced clostridium medium containing 5% (vol/
wt) skim milk (14). The two C. botulinum type B isolates were
genotyped by pulsed-field gel electrophoresis (PFGE) typing
(5) and randomly amplified polymorphic DNA (RAPD) anal-
ysis (7).
Isolation of DNA for PFGE was performed as previously
described (5). Samples were electrophoresed at 8°C through a
1% (wt/vol) agarose gel (SeaKem Gold agarose; BMA, Rock-
land, Maine) in 0.5 TBE buffer (Amresco, Solon, Ohio) at
200 V with a Gene Navigator system (Pharmacia, Uppsala,
Sweden) with a hexagonal electrode. With SmaI the running
time was 22 h with a pulse time ramp of 1 to 26 s, and with
XhoI the running time was 18 h with a pulse time ramp of 1 to
15 s. Low Range PFG marker (New England Biolabs, Beverly,
Mass.) was used for fragment size evaluation. RAPD analysis
was performed as previously described (7) with Ready-To-Go
RAPD analysis beads (Amersham Pharmacia Biotech Inc.,
Piscataway, N.J.). The thermal profile consisted of denatur-
ation at 95°C for 5 min, following 45 cycles of denaturation at
95°C for 1 min, annealing at 36°C for 1 min, and extension at
72°C for 2 min.
Both molecular typing methods indicated that the patient
intestinal isolate and the dust isolate of C. botulinum type B
were clonal (Fig. 1 and 2).
This study was the first instance in which PCR methodology
was successfully used to detect the botulinum toxin gene in
human intestinal contents. In addition, for the first time the C.
botulinum isolates from an intestinally colonized infant and
from household dust from the infant’s home were demon-
FIG. 1. PFGE patterns of the C. botulinum strains isolated from
the infant (lane 1) and from vacuum cleaner dust (lane 2). Digestion
was performed with restriction enzymes SmaI and XhoI. The outer-
most lanes contain Low Range PFG marker.
FIG. 2. RAPD patterns of the C. botulinum strains isolated from
the infant (lane 1) and from vacuum cleaner dust (lane 2). The patterns
were generated with universal primers OPJ-6 and OPJ-13. The outer-
most lanes contain molecular weight marker (MWM) VI.
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strated to be genetically similar. This genetic similarity suggests
that airborne spores of C. botulinum in an infant’s surround-
ings may cause infant botulism and, as in this case, also result
in the fulminant form of the illness that resembles SIDS. Pre-
vious studies have shown that C. botulinum is not a part of the
normal human infant intestinal microflora (4, 16, 17). Also,
because C. botulinum ordinarily competes poorly with other
intestinal bacteria, isolation of C. botulinum from the intestinal
contents suggests that a relatively large number of spores was
initially ingested, the organism multiplied substantially in the
intestinal lumen, or both. According to the case definition of
infant botulism used in the United States (3), infant botulism
is an illness consistent with the known paralyzing action of
botulinum toxin in which C. botulinum toxin and/or organisms
are identified in serum or fecal specimens. However, in prac-
tice botulinum toxin is rarely found in the serum of infant
botulism patients with fecally diagnosed illness (4). In accor-
dance with the U.S. definition, the case reported here may be
considered to be infant botulism and is the first case of infant
botulism to be recognized in Finland. Our experience suggests
that the possibility of this diagnosis should not be overlooked
in sudden infant death cases in countries with a low reported
incidence of infant botulism.
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